Maryland, learn from Colorado: Price controls on drugs can do more harm than good

In May 2019, Maryland became the first state to establish a board to set drug prices. But nearly five years later, the board still hasn’t determined which medicines deserve limits or how to apply them. Maryland was smart not to rush. There’s a distinct danger that cutting prices by government decree through a politically appointed Prescription Drug Affordability Board (PDAB) will do more harm than good. That’s certainly what Colorado is learning.